Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity (Unaudited)

v3.20.2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated (Deficit)
Total
Balance at Dec. 31, 2018 $ 27,949 $ 38,796,562 $ (8,765,992) $ 30,058,519
Balance, shares at Dec. 31, 2018 27,948,609      
Common stock issued upon warrant exercise $ 172 1,552 1,724
Common stock issued upon warrant exercise, shares 172,500      
Common stock issued upon cashless exercise of options $ 229 (229)
Common stock issued upon cashless exercise of options, shares 228,890      
Common stock issued in connection with business combinations $ 345 998,406 998,751
Common stock issued in connection with business combinations, shares 344,553      
Common stock issued for prepaid services $ 50 95,950 96,000
Common stock issued for prepaid services, shares 50,000      
Common stock issued for accrued share-based compensation $ 100 210,100 210,200
Common stock issued for accrued share-based compensation, shares 100,000      
Share based compensation   (8,951) (8,951)
Net income/loss   229,421 229,421
Balance at Mar. 31, 2019 $ 28,845 40,093,390 (8,536,571) 31,585,664
Balance, shares at Mar. 31, 2019 28,844,552      
Balance at Dec. 31, 2018 $ 27,949 38,796,562 (8,765,992) 30,058,519
Balance, shares at Dec. 31, 2018 27,948,609      
Net income/loss       2,341,120
Balance at Sep. 30, 2019 $ 36,652 59,178,587 (6,424,872) 52,790,367
Balance, shares at Sep. 30, 2019 36,652,105      
Balance at Mar. 31, 2019 $ 28,845 40,093,390 (8,536,571) 31,585,664
Balance, shares at Mar. 31, 2019 28,844,552      
Common stock issued upon warrant exercise $ 1,250 436,250   437,500
Common stock issued upon warrant exercise, shares 1,250,000      
Common stock issued upon cashless exercise of options $ 241 (241)
Common stock issued upon cashless exercise of options, shares 241,154      
Common stock issued in connection with business combinations $ 250 810,630 810,880
Common stock issued in connection with business combinations, shares 250,000      
Common stock issued for accrued share-based compensation $ 42 35,758 35,800
Common stock issued for accrued share-based compensation, shares 42,500      
Sales of common stock, net of fees $ 4,123 12,661,866 12,665,989
Sales of common stock, net of fees, shares 4,123,254      
Common stock issued for convertible debt $ 83 189,485 189,568
Common stock issued for convertible debt, shares 83,451      
Share based compensation   103,275 103,275
Net income/loss     1,062,000 1,062,000
Balance at Jun. 30, 2019 $ 34,834 54,330,413 (7,474,571) 46,890,676
Balance, shares at Jun. 30, 2019 34,834,911      
Common stock issued for convertible debt and cashless warrant exercise $ 1,175 2,214,528   2,215,703
Common stock issued for convertible debt and cashless warrant exercise, shares 1,175,157      
Common stock issued upon warrant exercise $ 300 824,906   825,206
Common stock issued upon warrant exercise, shares 299,963      
Common stock issued upon cashless exercise of options $ 36 (36)  
Common stock issued upon cashless exercise of options, shares 35,824      
Common stock issued in connection with business combinations $ 300 1,529,700   1,530,000
Common stock issued in connection with business combinations, shares 300,000      
Common stock issued for accrued share-based compensation $ 7 23,941   23,948
Common stock issued for accrued share-based compensation, shares 6,250      
Share based compensation   255,135   255,135
Net income/loss     1,049,699 1,049,699
Balance at Sep. 30, 2019 $ 36,652 59,178,587 (6,424,872) 52,790,367
Balance, shares at Sep. 30, 2019 36,652,105      
Balance at Dec. 31, 2019 $ 36,876 60,742,055 (6,887,188) 53,891,743
Balance, shares at Dec. 31, 2019 36,876,305      
Common stock issued upon warrant exercise $ 191 509,928 510,119
Common stock issued upon warrant exercise, shares 191,235      
Common stock issued upon cashless exercise of warrants $ 19 (19)
Common stock issued upon cashless exercise of warrants, shares 18,712      
Common stock issued upon cashless exercise of options $ 280 (280)
Common stock issued upon cashless exercise of options, shares 279,823      
Common stock issued in connection with business combinations $ 250 1,102,250 1,102,500
Common stock issued in connection with business combinations, shares 250,000      
Common stock issued for accrued share-based compensation $ 519 1,759,913 1,760,432
Common stock issued for accrued share-based compensation, shares 519,333      
Common stock issued for assets $ 24 100,800   100,824
Common stock issued for assets, shares 23,982      
Common stock issued for services $ 50 (50)
Common stock issued for services, shares 50,000      
Share based compensation   2,208,646 2,208,646
Net income/loss (2,093,518) (2,093,518)
Balance at Mar. 31, 2020 $ 38,209 66,423,243 (8,980,706) 57,480,746
Balance, shares at Mar. 31, 2020 38,209,300      
Balance at Dec. 31, 2019 $ 36,876 60,742,055 (6,887,188) 53,891,743
Balance, shares at Dec. 31, 2019 36,876,305      
Net income/loss       3,817,758
Balance at Sep. 30, 2020 $ 48,412 115,285,993 (3,069,430) 112,264,975
Balance, shares at Sep. 30, 2020 48,412,292      
Balance at Mar. 31, 2020 $ 38,209 66,423,243 (8,980,706) 57,480,746
Balance, shares at Mar. 31, 2020 38,209,300      
Common stock issued upon warrant exercise $ 81 282,180 282,261
Common stock issued upon warrant exercise, shares 80,646      
Common stock issued upon cashless exercise of warrants $ 78 (78)
Common stock issued upon cashless exercise of warrants, shares 77,907      
Common stock issued upon cashless exercise of options $ 30 (30)
Common stock issued upon cashless exercise of options, shares 29,792      
Common stock issued in connection with business combinations $ 107 705,093 705,200
Common stock issued in connection with business combinations, shares 107,500      
Common stock issued for accrued share-based compensation $ 5 24,845 24,850
Common stock issued for accrued share-based compensation, shares 5,000      
Common stock issued for assets $ 10 67,490 67,500
Common stock issued for assets, shares 10,000      
Common stock issued for accrued compensation $ 325 717,206 717,531
Common stock issued for accrued compensation, shares 324,674      
Share based compensation   1,162,055 1,162,055
Net income/loss     2,573,943 2,573,943
Balance at Jun. 30, 2020 $ 38,845 69,382,004 (6,406,763) 63,014,086
Balance, shares at Jun. 30, 2020 38,844,819      
Sale of common stock, net of offering costs $ 8,625 44,611,040   44,619,665
Sale of common stock, net of offering costs, shares 8,625,000      
Common stock issued upon warrant exercise $ 88 271,665   271,753
Common stock issued upon warrant exercise, shares 87,823      
Common stock issued upon cashless exercise of warrants $ 570 (570)  
Common stock issued upon cashless exercise of warrants, shares 570,172      
Common stock issued upon cashless exercise of options $ 164 (164)  
Common stock issued upon cashless exercise of options, shares 164,438      
Common stock issued for accrued share-based compensation $ 120 43,801   43,921
Common stock issued for accrued share-based compensation, shares 120,040      
Share based compensation   978,217   978,217
Net income/loss     3,337,333 3,337,333
Balance at Sep. 30, 2020 $ 48,412 $ 115,285,993 $ (3,069,430) $ 112,264,975
Balance, shares at Sep. 30, 2020 48,412,292